Treatment with PRGF regenerative technology
PRGF is an abbreviation for Plasma Rich in Growth Factors. Growth factors are proteins which perform a key role in the complex process of tissue repair and regeneration. The therapeutic application of growth factors stimulates and accelerates wound healing and tissue regeneration process. They mediate and control different biological processes including early and late inflammation phases, proliferation and migration of cells, angiogenesis, granulation tissue formation and finally matrix formation and remodeling.
The development of regenerative medicine has made it possible to use the human body's own resources to heal itself. BTI's research team has developed the therapeutic use of plasma rich in growth factors (PRGF®-Endoret®), a technique that enables an efficient regeneration of tissues, without side-effects and notably reducing the recovery period of fractures and lesions.
PRGF®-Endoret® technology is scientifically backed by both its effectiveness and its safety, with the publication of over one hundred scientific articles in specialized journals and its presentation at hundreds of congresses.
In addition, PRGF®-Endoret® technology is applicable in many fields of medicine in which its high level of effectiveness has been proven: oral and maxillofacial surgery, orthopaedics and sports medicine, dermatology, ophthalmology, vascular surgery, plastic and cosmetic surgery and even veterinary surgery.
We are offering bone grafting and skin regeneration applications of PRGF technology.
It involves collection of 30cc of patients blood at the time of procedure and preparing it into PRGF fractions that are then reintroduced to the surgical site.